Man Group plc

Position in BHC — Bausch Health Companies Inc.

CIK 1637460 LONDON, X0

Position in BHC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,157,279

+$4,307,943 QoQ

Shares Held

1,451,781

+175.1% QoQ

Ownership

0.388%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#26

of 220 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 63% Shared 0% None 37%

Healthcare · as of Jun 30, 2026

Man Group plc holds $452,779,482 across 30 Drug Manufacturers - Specialty & Generic names. BHC ranks #8 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,805,003	$129,707,515
2	NBIX	Neurocrine Biosciences Inc	601,019	$101,295,742
3	UTHR	UNITED THERAPEUTICS Corp	134,890	$73,087,447
4	VTRS	Viatris Inc	3,523,052	$55,946,065
5	PRGO	PERRIGO Co plc	1,530,206	$15,898,840
6	BCRX	Biocryst Pharmaceuticals Inc	732,867	$7,328,670
7	SUPN	Supernus Pharmaceuticals, Inc.	156,422	$7,275,186
8	BHC	Bausch Health Companies Inc. This page	1,451,781	$7,157,279

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,157,279	1,451,781	+175.1%	Shares	Defined	2026-08-14
2026-03-31	$2,849,336	527,655	-12.4%	Shares	Defined	2026-05-15
2025-12-31	$4,184,789	602,128	-7.6%	Shares	Defined	2026-02-17
2024-06-30	$4,544,077	651,948	-61.6%	Shares	Defined	2024-08-14
2024-03-31	$18,007,451	1,697,215	-3.0%	Shares	Defined	2024-05-15
2023-12-31	$14,028,792	1,749,226	+184.8%	Shares	Defined	2024-02-14
2023-09-30	$5,462,091	664,488	+204.0%	Principal	Defined	2023-11-14
2023-06-30	$4,914,304	614,288	+1306.3%	Shares	Defined	2023-08-14
2022-09-30	$300,955	43,680	-68.1%	Shares	Sole	2022-11-14
2022-06-30	$1,827,303	218,577	—	Principal	Defined	2022-08-15
2020-12-31	$2,848,497	136,947	+509.5%	Shares	Defined	2021-02-16
2020-09-30	$349,137	22,467	+43.1%	Shares	Defined	2020-11-16
2020-03-31	$243,350	15,700	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.